# Elemene Liposomes in Endometrial Cancer

> **NCT07738315** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Women's Hospital School Of Medicine Zhejiang University** · enrollment: 212 (estimated)

## Conditions studied

- Endometrial Carcinoma

## Interventions

- **DRUG:** Elemene Injection/Elemene Oral Emulsion
- **DRUG:** Carboplatin-Paclitaxel chemotherapy

## Key facts

- **NCT ID:** NCT07738315
- **Lead sponsor:** Women's Hospital School Of Medicine Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2031-08
- **Final completion:** 2031-09
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2026-07-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07738315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07738315, "Elemene Liposomes in Endometrial Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07738315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*